Press release
Investigation was announced for Investors in shares of BeiGene, Ltd. (NASDAQ: BGNE)
An investigation for investors in BeiGene, Ltd. (NASDAQ: BGNE) shares over potential securities laws violations by BeiGene, Ltd.
Investors who purchased shares of BeiGene, Ltd. (NASDAQ: BGNE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by BeiGene, Ltd. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
China based BeiGene, Ltd., a commercial-stage biotechnology company, develops and commercializes molecularly-targeted and immuno-oncology drugs for the treatment of cancer in the People's Republic of China, the United States, and internationaly.
On September 5, 2019, a report was published concerning BeiGene, Ltd. The report asserted, inter alia, that BeiGene “is faking sales in order to persuade investors that it can develop a successful platform in China” and that “management may also be skimming R&D and capital budgets.”
Shares of BeiGene, Ltd. (NASDAQ: BGNE) declined to as low as $118.00 per share on September 6, 2019.
Those who purchased shares of BeiGene, Ltd. (NASDAQ: BGNE) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation was announced for Investors in shares of BeiGene, Ltd. (NASDAQ: BGNE) here
News-ID: 1833537 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for BeiGene
Leiomyosarcoma Drug Market Sluggish Growth Rate Foreseen by 2021-2027 with Covid …
This Leiomyosarcoma Drug market report provides a clear picture of key players' growth as well as the qualitative aspects of business in each area. This Leiomyosarcoma Drug Market Report provides a current report on revenue generation, recent trends, financial status, and costing, as well as business profiles and financial status. The competitive landscape and potential growth factors are presented in this Leiomyosarcoma Drug Market Report. This will…
Bruton's Tyrosine Kinase (BTK) Inhibitors Market 2021 Analysis - Johnson & Johns …
An influential Bruton's Tyrosine Kinase (BTK) Inhibitors Market report is a thorough investigation of the current scenario of the global market, which covers several market dynamics. Moreover, for the businesses, it is the most important to get a knowhow of consumer’s demands, preferences, attitudes and their changing tastes about the specific product which can be studied via this report. To get knowledge of all the above things, this market report…
Global Merkel Cell Carcinoma Treatment Market 2020 Business Strategies – Amgen …
The Zion Market Research added a new report “Merkel Cell Carcinoma Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting.
Merkel Cell Carcinoma Treatment Market Market research report which provides an in-depth examination of the market scenario…
Investigation for Investors in NASDAQ: BGNE shares over possible Wrongdoing at B …
An investigation on behalf of current long-term investors in shares of BeiGene, Ltd. (NASDAQ: BGNE) was announced over potential breaches of fiduciary duties by certain officers and directors at BeiGene, Ltd.
Investors who purchased shares of BeiGene, Ltd. (NASDAQ: BGNE) and currently hold any of those NASDAQ: BGNE shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
Biomarkers and Companion Diagnostics in Oncology 2019| Abbott Molecular, Amoy Di …
Albany, NY, 30th January : Recent research and the current scenario as well as future market potential of "Biomarkers and Companion Diagnostics in Oncology" globally.
A biomarker is a defined molecular characteristic, for example a genetic mutation, that can tell a physician more about a patients disease state, or how they might respond to treatment. Predictive biomarkers indicate how likely a patient is to respond to a treatment, and are used…
Global Diffuse Large B Cell Lymphoma Drug Market 2018 - AbbVie, BeiGene, Celltri …
Apex Market Reports, recently published a detailed market research study focused on the “Diffuse Large B Cell Lymphoma Drug Market” across the global, regional and country level. The report provides 360° analysis of “Diffuse Large B Cell Lymphoma Drug Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and…
